Metaplastic breast carcinoma: sonographic and clinicopathologic comparison with infiltrating ductal carcinoma

Author:

Yao Mengxia1,Wang Yin1,Li Lian2,Luo Siwei1,Zhu Wu1,Liu Yu1,Liang Changhong1

Affiliation:

1. Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences, Southern Medical University

2. Southern Medical University

Abstract

Abstract Background:There are limited data on the sonographic findings about metaplastic breast carcinoma (MBC) due to its rarity. This article aimed to determine the value of sonographic and clinicopathologic features in improving diagnostic accuracy of MBC and distinguishing it from infiltrating ductal carcinoma(IDC). Methods: In the present study, 197 women (200 lesions) with IDC and 20 women (20 lesions) with MBC were retrospectively reviewed. Sonographic and clinicopathologic characteristics were compared between MBC and IDC. Results: Relative to IDC, most of MBC were tumor grade III(95.0% vs 32.5%, P<0.001), with high Ki67(100.0% vs 75.0%, P<0.001) and triple negative subtype (90.0% vs 13.0%, P<0.001). On ultrasound findings, lesions of MBC tended to have big size (≥5cm,45.0% vs 1.5%, P<0.001), regular shape (45.0% vs 1.5%, P<0.001), circumscribed margin (40.0% vs 0.5%, P<0.001), complex cystic and solid echo(50.0% vs 3.5%, P<0.001) and posterior acoustic enhancement(95.0% vs 14.5%, P<0.001). The most important factors in distinguishing these two tumors were posterior acoustic enhancement, circumscribed margin and size by multilayer perceptron. In MBC cases, the estimated rate of local recurrence, distant metastasis and 5-year overall survival was 10.0%, 30.0% and 65.0%. Conclusions: MBC is mainly manifested as a large breast mass with benign ultrasound findings in elderly women, which may be helpful for diagnosis of MBC and its differential diagnosis from other masses.

Publisher

Research Square Platform LLC

Reference30 articles.

1. WHO Classifcation Of Tumors Editorial Board: WHO classification of tumors, 5th edition - Breast tumors. Lyon: International Agency for Research on Cancer. ; 2019. https://publications.iarc.fr/581.

2. Clinicopathologic Characteristics and Outcome Descriptors of Metaplastic Breast Carcinoma;Abada E;ARCH PATHOL LAB MED,2022

3. Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy;Al-Hilli Z;BREAST CANCER RES TR,2019

4. Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy;Al-Hilli Z;BREAST CANCER RES TR,2019

5. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature;Zein D;CLIN BREAST CANCER,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3